everytihng about Coluracetam
Inquiry
| Post Date: | Apr 13,2016 |
| Expiry Date: | Apr 13,2017 |
| Detailed Description: |
Cas No. :135463-81-9
Payment Method: within 24 hours after receipt of the payment Coluracetam Keywords:nootropics Piracetam,Aniracetam,Pramiracetam,Oxiracetam, Coluracetam,Phenylpiracetam smart drugs Piracetam,Aniracetam, Pramiracetam,Oxiracetam,Coluracetam,Phenylpiracetam hot sale nootropics CAS No:135463-81-9 Purity:99% Appearance:white crystalline powder Package:1kg/bag. Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD).BrainCells Inc is currently out-licensing the drug for this purpose.It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury. Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system. |
| CAS Registry Number: | 135463-81-9 |
| Synonyms: | N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide |
| Molecular Formula: | C19H23N3O3 |
| Molecular Weight: | 341.4042 |
| Molecular Structure: | 
|
| Company: | Koffee Pharm Co., Ltd. [ China ] |
| Contact: | sophia simith |
| Tel: | +86-21-61729394 |
| Fax: | +86-21-61729394 |
| Email: | sophia@koffeepharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
